DAPK-IN-2
DAPK-IN-2 is a DAPK inhibitor. DAPK-IN-2 can be used for the research of cerebral infarction and ischemic diseases[1].
Product Specifications
CAS Number
[304000-05-3]
UNSPSC
12352005
Hazard Statement
H302-H315-H319
Target
DAPK
Type
Reference compound
Related Pathways
Apoptosis
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/dapk-in-2.html
Purity
98.02
Solubility
DMSO : 2 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C1OC(C2=CC(OC)=C(OC)C=C2)=N/C1=C\C3=CC=CN=C3
Molecular Formula
C17H14N2O4
Molecular Weight
310.30
Precautions
P264-P270-P280-P302+P352-P305+P351+P338-P330-P362+P364-P501
References & Citations
[1]Okamoto M, et al. Structure-activity relationship of novel DAPK inhibitors identified by structure-based virtual screening. Bioorg Med Chem. 2010;18 (7) :2728-2734.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15253413 1 Vial
Lentiviral mouse Efnb3 shRNA (UAS) - Lentiviral mouse Efnb3 shRNA (UAS, GFP) (100)
Ask
View Details